MoneyWorks4Me

Ipca Laboratories - Quaterly Results

29 May 2024 Evaluate
The company witnessed a 7.78% growth in the revenue at Rs. 15106.20 millions for the quarter ended March 2024 as compared to Rs. 14016.30 millions during the year-ago period.The Company's Net profit for the March 2024 quarter have declined marginally to Rs. 647.60  millions as against Rs. 848.20 millions reported during the corresponding quarter ended.OP of the company witnessed a marginal growth to 3074.40 millions from 2091.10 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 15106.20 14016.30 7.78 61664.60 58146.20 6.05 61664.60 58146.20 6.05
Other Income 151.00 334.70 -54.88 1112.90 1111.90 0.09 1112.90 1111.90 0.09
PBIDT 3074.40 2091.10 47.02 13226.70 10230.40 29.29 13226.70 10230.40 29.29
Interest 240.60 176.90 36.01 1206.70 439.20 174.75 1206.70 439.20 174.75
PBDT 1890.60 1914.20 -1.23 10686.40 9791.20 9.14 10686.40 9791.20 9.14
Depreciation 617.60 592.10 4.31 2464.80 2286.30 7.81 2464.80 2286.30 7.81
PBT 1273.00 1322.10 -3.71 8221.60 7504.90 9.55 8221.60 7504.90 9.55
TAX 625.40 473.90 31.97 2917.50 2447.90 19.18 2917.50 2447.90 19.18
Deferred Tax 6.30 84.40 -92.54 37.40 208.40 -82.05 37.40 208.40 -82.05
PAT 647.60 848.20 -23.65 5304.10 5057.00 4.89 5304.10 5057.00 4.89
Equity 253.70 253.70 0.00 253.70 253.70 0.00 253.70 253.70 0.00
PBIDTM(%) 20.35 14.92 36.42 21.45 17.59 21.91 21.45 17.59 21.91
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..